The adrenal specific toxicant mitotane directly interacts with lipid membranes and alters membrane properties depending on lipid composition.

作者: Holger A. Scheidt , Ivan Haralampiev , Stephan Theisgen , Andreas Schirbel , Silviu Sbiera

DOI: 10.1016/J.MCE.2016.03.022

关键词:

摘要: Mitotane (o,p'.-DDD) is an orphan drug approved for the treatment of adrenocortical carcinoma. The mechanisms, which are responsible this activity drug, not completely understood. It can be hypothesized that impact mitotane mediated by interaction with cellular membranes. However, (lipid) membranes has yet been investigated in detail. Here, we characterized and its main metabolite o,p'-dichlorodiphenyldichloroacetic acid (o,p'-DDA) lipid applying a variety biophysical approaches nuclear magnetic resonance, electron spin fluorescence spectroscopy. We found o,p'-DDA bind to inserting into lipid-water interface bilayer. but directly causes disturbance bilayer structure leading increased permeability membrane polar molecules. induced alterations integrity required presence phosphatidylethanolamine and/or cholesterol. Collectively, our data first time characterize on dynamics, may contribute better understanding specific effects side effects.

参考文章(70)
Zaggia B, Daffara F, Ardito A, Germano A, Berruti A, De Francia S, Di Carlo F, Mitotane treatment for adrenocortical carcinoma: an overview. Minerva Endocrinologica. ,vol. 37, pp. 9- 23 ,(2012)
Stefanie Hahner, Martin Fassnacht, Mitotane for adrenocortical carcinoma treatment. Current opinion in investigational drugs. ,vol. 6, pp. 386- 394 ,(2005)
Peter Müller, Anna Pia Plazzo, Andreas Herrmann, Transbilayer Movement and Distribution of Cholesterol John Wiley & Sons, Inc.. pp. 75- 96 ,(2011) , 10.1002/9781118120118.CH5
Mahmoud L. Nasr, Xiaomeng Shi, Anna L. Bowman, Michael Johnson, Nikolai Zvonok, David R. Janero, V. Kiran Vemuri, Thomas E. Wales, John R. Engen, Alexandros Makriyannis, Membrane phospholipid bilayer as a determinant of monoacylglycerol lipase kinetic profile and conformational repertoire Protein Science. ,vol. 22, pp. 774- 787 ,(2013) , 10.1002/PRO.2257
Matthias Kroiss, Marcus Quinkler, Werner K. Lutz, Bruno Allolio, Martin Fassnacht, Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma Clinical Endocrinology. ,vol. 75, pp. 585- 591 ,(2011) , 10.1111/J.1365-2265.2011.04214.X
A Zachowski, Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochemical Journal. ,vol. 294, pp. 1- 14 ,(1993) , 10.1042/BJ2940001
Ségolène Hescot, Atmane Seck, Maryse Guerin, Florence Cockenpot, Thierry Huby, Sophie Broutin, Jacques Young, Angelo Paci, Eric Baudin, Marc Lombès, Lipoprotein-Free Mitotane Exerts High Cytotoxic Activity in Adrenocortical Carcinoma The Journal of Clinical Endocrinology and Metabolism. ,vol. 100, pp. 2890- 2898 ,(2015) , 10.1210/JC.2015-2080
James H. Davis, The description of membrane lipid conformation, order and dynamics by 2H-NMR Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes. ,vol. 737, pp. 117- 171 ,(1983) , 10.1016/0304-4157(83)90015-1
Andreas Herrmann, Alain Zachowski, Philippe F. Devaux, Protein-mediated phospholipid translocation in the endoplasmic reticulum with a low lipid specificity. Biochemistry. ,vol. 29, pp. 2023- 2027 ,(1990) , 10.1021/BI00460A010
Martin Fassnacht, Matthias Kroiss, Bruno Allolio, Update in Adrenocortical Carcinoma The Journal of Clinical Endocrinology and Metabolism. ,vol. 98, pp. 4551- 4564 ,(2013) , 10.1210/JC.2013-3020